Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | DNA repair protein RAD51, putative | 0.011 | 0.7222 | 1 |
Echinococcus granulosus | DNA excision repair protein ERCC 1 | 0.0075 | 0.3839 | 0.5316 |
Trypanosoma brucei | protein kinase, putative | 0.0039 | 0.0428 | 1 |
Entamoeba histolytica | DNA repair protein RAD51, putative | 0.011 | 0.7222 | 1 |
Giardia lamblia | DNA helicase | 0.0075 | 0.3839 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0039 | 0.0428 | 0.0592 |
Toxoplasma gondii | meiotic recombination protein DMC1 family protein | 0.011 | 0.7222 | 1 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0039 | 0.0428 | 0.0592 |
Trichomonas vaginalis | meiosis-specific recA homolog Dmc1 | 0.011 | 0.7222 | 1 |
Giardia lamblia | Kinase, CMGC GSK | 0.0039 | 0.0428 | 0.0916 |
Mycobacterium leprae | Probable Holliday junction DNA helicase component RuvA | 0.0075 | 0.3839 | 0.5 |
Trypanosoma cruzi | meiotic recombination protein DMC1, putative | 0.011 | 0.7222 | 1 |
Mycobacterium tuberculosis | Probable holliday junction DNA helicase RuvA | 0.0075 | 0.3839 | 0.5 |
Onchocerca volvulus | 0.0039 | 0.0428 | 0.0428 | |
Chlamydia trachomatis | excinuclease ABC subunit C | 0.0075 | 0.3839 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | Holliday junction DNA helicase RuvA | 0.0075 | 0.3839 | 0.5 |
Trypanosoma cruzi | meiotic recombination protein DMC1, putative | 0.011 | 0.7222 | 1 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0039 | 0.0428 | 1 |
Echinococcus multilocularis | protein kinase shaggy | 0.0039 | 0.0428 | 0.0592 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0139 | 1 | 1 |
Leishmania major | RAD51/dmc1 protein | 0.011 | 0.7222 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0039 | 0.0428 | 0.0482 |
Chlamydia trachomatis | exodeoxyribonuclease V subunit alpha | 0.0075 | 0.3839 | 0.5 |
Echinococcus granulosus | dna repair protein rad51 1 | 0.011 | 0.7222 | 1 |
Mycobacterium ulcerans | excinuclease ABC subunit C | 0.0075 | 0.3839 | 0.5 |
Onchocerca volvulus | Meiotic recombination protein DMC1\/LIM15 homolog | 0.0035 | 0.0084 | 0.0084 |
Toxoplasma gondii | DNA repair protein rad10 subfamily protein | 0.0075 | 0.3839 | 0.5261 |
Echinococcus multilocularis | DNA excision repair protein ERCC 1 | 0.0075 | 0.3839 | 0.5316 |
Trypanosoma cruzi | DNA repair protein RAD51, putative | 0.011 | 0.7222 | 1 |
Wolbachia endosymbiont of Brugia malayi | transcription elongation factor NusA | 0.0075 | 0.3839 | 0.5 |
Brugia malayi | Meiotic recombination protein DMC1/LIM15 homolog, putative | 0.0035 | 0.0084 | 0.0084 |
Echinococcus multilocularis | dna repair protein rad51 1 | 0.011 | 0.7222 | 1 |
Loa Loa (eye worm) | rad51 | 0.011 | 0.7222 | 0.7222 |
Mycobacterium ulcerans | Holliday junction DNA helicase RuvA | 0.0075 | 0.3839 | 0.5 |
Chlamydia trachomatis | Holliday junction ATP-dependent DNA helicase RuvA | 0.0075 | 0.3839 | 0.5 |
Echinococcus granulosus | protein kinase shaggy | 0.0039 | 0.0428 | 0.0592 |
Brugia malayi | DNA repair protein RAD51 homolog 1 | 0.011 | 0.7222 | 0.7222 |
Schistosoma mansoni | excision repair cross-complementing 1 ercc1 | 0.0075 | 0.3839 | 0.5316 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0039 | 0.0428 | 0.0428 |
Treponema pallidum | Holliday junction DNA helicase (ruvA) | 0.0075 | 0.3839 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0039 | 0.0428 | 0.0482 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0039 | 0.0428 | 0.0428 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0039 | 0.0428 | 0.0592 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0039 | 0.0428 | 0.0482 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0039 | 0.0428 | 0.0482 |
Schistosoma mansoni | DNA repair protein RAD51 | 0.011 | 0.7222 | 1 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0039 | 0.0428 | 1 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0039 | 0.0428 | 0.0482 |
Giardia lamblia | hypothetical protein | 0.0075 | 0.3839 | 1 |
Giardia lamblia | Kinase, CMGC GSK | 0.0039 | 0.0428 | 0.0916 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0039 | 0.0428 | 0.0482 |
Loa Loa (eye worm) | meiotic recombination protein DMC1/LIM15 | 0.0035 | 0.0084 | 0.0084 |
Brugia malayi | intracellular kinase | 0.0039 | 0.0428 | 0.0428 |
Entamoeba histolytica | protein kinase, putative | 0.0039 | 0.0428 | 0.0482 |
Chlamydia trachomatis | DNA ligase | 0.0075 | 0.3839 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | > 35 uM | PUBCHEM_BIOASSAY: MITF: Counter assay: A375 proliferation Measured in Cell-Based System Using Plate Reader - 2084-03_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488944] | ChEMBL. | No reference |
AC50 (functional) | > 35 uM | PUBCHEM_BIOASSAY: MITF: Counter assay: A375 proliferation Measured in Cell-Based System Using Plate Reader - 2084-03_Inhibitor_Dose_CherryPick_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488944] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.